Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Arda Kiani and Farzaneh Dastan.
Connection Strength

0.893
  1. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
    View in: PubMed
    Score: 0.224
  2. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):10-12.
    View in: PubMed
    Score: 0.221
  3. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341.
    View in: PubMed
    Score: 0.220
  4. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
    View in: PubMed
    Score: 0.058
  5. Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299.
    View in: PubMed
    Score: 0.057
  6. NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos. 2020 Nov; 19(2):91-99.
    View in: PubMed
    Score: 0.057
  7. Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.